NGEN

Encode Ideas, L.P. Announces the Initiation of Research Coverage on NervGen Pharma Corp.

Monday, September 13, 2021 - 2:00pm

Dover, Delaware--(Newsfile Corp. - September 13, 2021) - Encode Ideas, L.P. Initiates Research on NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF).

Key Points: 
  • Dover, Delaware--(Newsfile Corp. - September 13, 2021) - Encode Ideas, L.P. Initiates Research on NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF).
  • Encode Ideas, L.P., a healthcare focused research firm, announced today it is initiating coverage on NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF).
  • Encode Ideas, L.P. is a healthcare focused research firm, founded in 2019, providing institutional quality research and investment ideas.
  • Encode Ideas, L.P. has been retained by NervGen, Inc. to provide investor awareness and research coverage.